Is adjuvant radiotherapy necessary for FIGO stage 1a grade 2 endometrial endometrioid adenocarcinoma? | Zendy

Abdurrahman Hamdi İnan | Zendy; Gülçı̇n Şahin Ersoy | Zendy; Yusuf Yıldırım | Zendy; Tutku Gürbüz | Zendy; Ayşe Gül Kebapçılar | Zendy; Merih Hanhan | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Is adjuvant radiotherapy necessary for FIGO stage 1a grade 2 endometrial endometrioid adenocarcinoma?

Author(s) -

Abdurrahman Hamdi İnan,

Gülçı̇n Şahin Ersoy,

Yusuf Yıldırım,

Tutku Gürbüz,

Ayşe Gül Kebapçılar,

Merih Hanhan

Publication year - 2015

Publication title -

journal of the turkish-german gynecological association

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.346

H-Index - 16

eISSN - 1309-0399

pISSN - 1309-0380

DOI - 10.5152/jtgga.2015.15163

Subject(s) - medicine , radiation therapy , stage (stratigraphy) , endometrial cancer , adjuvant , distant metastasis , adjuvant radiotherapy , adenocarcinoma , survival rate , oncology , surgery , metastasis , cancer , paleontology , biology

The impact of adjuvant radiotherapy on the rates of survival and local recurrence was analyzed in patients diagnosed with International Federation of Gynecology and Obstetrics (FIGO) stage 1a grade 2 endometrial endometrioid adenocarcinoma.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research